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Recent studies by the American Society of Bone Marrow Trans-
plantation (ASBMT) have projected an increase in the number of he-
matopoietic stem cell transplants (HSCT)in the coming years, which
will grow the need for clinical pharmacists specialized in caring for
HSCT patients. However, major deterrents to meeting this in-
creased demand of HSCT Clinical Pharmacists are the low capacity
of residency training programs and exposure to HSCT as a student
or resident learner.
The Partnership in Patient Care (PIPC) initiative is a joint ef-
fort between the UNC Eshelman School of Pharmacy and the
UNC Hospitals’ Department of Pharmacy, with a goal to improve
patient care by expanding patient care services of the pharmacy
team, while improving the overall experience and capacity for
learners. The HSCT acute care service, as part of the PIPC initia-
tive, conducted a pilot program to evaluate the feasibility of in-
creasing learner capacity while expanding pharmacy services.
The pilot represented a paradigm shift from a model where the
clinical specialist (CS) was the major driver of outcomes to the
CS evolving into an Attending Pharmacist (AP) and managing
a pharmacy team to drive the direct patient care outcomes. A lay-
ered learning practice model (LLPM) was created where the AP
oversees Decentral Pharmacists (DP), a resident, and a student.
Improvements during the LLPM included 100% capture rate of
new admission medication histories, completion of all patients’
pre-discharge insurance benefits investigation, accomplishing
100% compliance for the National Patient Safety Goals of medi-
cation reconciliation and discharge counseling, and formal docu-
mentation of pharmacy activities in the patient’s electronic
medical record (Table 1). Mobilizing learners through the
LLPM allowed them more time spent directly with the patient
to create a stronger pharmacist-patient relationship. The ability
of the AP to delegate responsibilities for pharmacy activities in-
creased educational opportunities and increased the sense of own-
ership to offer a wider range of pharmacy services to the patient
and for the medical team. While challenges exist and the model re-Table. Correlation of Quality of Life and Medication Burden
QoL Domain
Total number of
scheduled pills per day
p (p)
Maximum poss
per day (schedul
r r
Pre-HSCT Pre-HSCT (N 5 43)
Physical well being -0.22 0.15 (0.41) -0.44
Social well being -0.37 0.02 (0.01) -0.26
Emotional well being -0.06 0.69 (0.91) 0.16
Functional well being -0.16 0.3 (0.55) -0.39
Overall QoL -0.25 0.11 (0.27) -0.43
1 Year Post-HSCT Pre-HSCT (N 5 41)
Physical well being -0.05 0.75 (0.81) -0.47
Social well being 0.12 0.44 (0.94) -0.03
Emotional well being 0.08 0.64 (0.62) -0.30
Functional well being 0.14 0.37 (0.35) -0.23
Overall QoL 0.08 0.61 (0.54) -0.38
1 Year Post-HSCT 1 Year Post-HSCT (N 5 41)
Physical well being -0.17 0.30 (0.61) -0.60
Social well being -0.21 0.18 (0.17) -0.20
Emotional well being 0.22 0.17 (0.11) -0.12
Functional well being -0.09 0.58 (0.99) -0.36
Overall QoL -0.10 0.54 (0.93) -0.47
r 5 Pearson correlation coefficient (p) 5 adjusted for age, gender, ECOG pe
S240quires further improvements to create sustainability, the patient
benefits gained during these pilots are significant enough to pursue
continuation of this model in the HSCT setting.
Table 1. PIPC Initiative Accomplishment
Non LLPM LLPMible doses
ed and prn)
p (p)
Maximum possib
day (scheduled
r
0.003 (0.01) -0.40
0.09 (0.05) -0.32
0.30 (0.35) -0.18
0.01 (0.04) -0.31
0.003 (0.01) -0.40
0.002 (0.002) -0.45
0.83 (0.29) -0.13
0.06 (0.07) -0.30
0.14 (0.07) -0.24
0.02 (0.006) -0.39
<0.0001 (0.0004) -0.68
0.22 (0.13) -0.24
0.47 (0.55) -0.20
0.02 (0.06) -0.43
0.002 (0.007) -0.57
rformance statusMonthsle pills per
and prn)
p (
0.008 (
0.04
0.24
0.04 (
0.008 (
0.003 (
0.42 (
0.06 (
0.13 (
0.01 (
<0.0001 (
0.13 (
0.22 (
0.005 (
0.0001 (MonthsTangible Benefits (100% Capture
Rate)Admission History Review x x
Admission Interview By Students x
Admission Chemotherapy Counseling x
Admission Medication Reconciliation x x
Discharge Medication Review x x
Discharge Counseling by Student/
Resident
xDischarge Insurance Benefits
InvestigationxDischarge Rx Facilitation x x
Discharge Summaries x
Intangible Benefits
Increased DP involvement x
Increased Pharmacy FSR Involvement x
Increase Awareness of Pharmacy
Services/Functions
xIncreased Resident Awareness of
Practical CS DutiesxIncreased Pharmacy Visibility and
ResponsibilityxCS indicates Clinical Specialist; DP, Decentral Pharmacist; FSR, Financial
Services Representative.
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Background: Literature suggests medication burden is related to
patient satisfaction; this relationship has not been examined in allo-
geneic hematopoietic stem cell transplant (aHSCT) patients. Wep)
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